131 related articles for article (PubMed ID: 38755237)
1. Comparison of different treatment strategies for T3N1-3 stage gastric cancer based on the SEER database.
Tan Y; Liu S; Tao S; Cheng H; Huang M; Tang Q
Sci Rep; 2024 May; 14(1):11210. PubMed ID: 38755237
[TBL] [Abstract][Full Text] [Related]
2. Improving survival of stage II-III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy.
Li Y; Zhu Z; Ma F; Xue L; Tian Y
Cancer Med; 2020 Sep; 9(18):6617-6628. PubMed ID: 32744431
[TBL] [Abstract][Full Text] [Related]
3. Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population-based study.
Shi T; Song X; Liu Q; Yang Y; Yu L; Liu B; Wei J
Cancer Med; 2019 Oct; 8(13):6010-6020. PubMed ID: 31448584
[TBL] [Abstract][Full Text] [Related]
4. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database.
Smith DD; Schwarz RR; Schwarz RE
J Clin Oncol; 2005 Oct; 23(28):7114-24. PubMed ID: 16192595
[TBL] [Abstract][Full Text] [Related]
5. Gastrectomy for stage IV gastric cancer: a comparison of different treatment strategies from the SEER database.
Desiderio J; Sagnotta A; Terrenato I; Annibale B; Trastulli S; Tozzi F; D'Andrea V; Bracarda S; Garofoli E; Fong Y; Woo Y; Parisi A
Sci Rep; 2021 Mar; 11(1):7150. PubMed ID: 33785761
[TBL] [Abstract][Full Text] [Related]
6. Population-based outcome of stage IA-IIA resected gastric adenocarcinoma: who should get adjuvant treatment?
Gold JS; Al Natour RH; Saund MS; Yoon C; Sharma AM; Huang Q; Boosalis VA; Whang EE
Ann Surg Oncol; 2013 Jul; 20(7):2304-10. PubMed ID: 23344580
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant radiation therapy increases overall survival in node-positive gastric cancer patients with aggressive surgical resection and lymph node dissection: a SEER database analysis.
Shridhar R; Dombi GW; Weber J; Hoffe SE; Meredith K; Konski A
Am J Clin Oncol; 2012 Jun; 35(3):216-21. PubMed ID: 21378540
[TBL] [Abstract][Full Text] [Related]
8. Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer.
Che K; Liu F; Wu N; Liu Q; Yuan L; Wei J
Cancer Med; 2020 Oct; 9(19):7137-7150. PubMed ID: 32810384
[TBL] [Abstract][Full Text] [Related]
9. A Prognostic Model for Patients With Gastric Signet Ring Cell Carcinoma.
Guo Q; Wang Y; An J; Wang S; Dong X; Zhao H
Technol Cancer Res Treat; 2021; 20():15330338211027912. PubMed ID: 34190015
[TBL] [Abstract][Full Text] [Related]
10. Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States.
Le A; Berger D; Lau M; El-Serag HB
Ann Surg Oncol; 2007 Sep; 14(9):2519-27. PubMed ID: 17610016
[TBL] [Abstract][Full Text] [Related]
11. Incidence, Survival, and Predictors of Lymph Node Involvement in Early-Stage Gastric Signet Ring Cell Carcinoma in the US.
Pokala SK; Zhang C; Chen Z; Gamboa AM; Cristofaro SL; Keilin SA; Cai Q; Willingham FF
J Gastrointest Surg; 2018 Apr; 22(4):569-577. PubMed ID: 29313289
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysis.
Stumpf PK; Amini A; Jones BL; Koshy M; Sher DJ; Lieu CH; Schefter TE; Goodman KA; Rusthoven CG
Cancer; 2017 Sep; 123(17):3402-3409. PubMed ID: 28513823
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.
He MM; Zhang DS; Wang F; Wang ZQ; Luo HY; Ren C; Jin Y; Chen DL; Xu RH
World J Gastroenterol; 2014 Jan; 20(1):264-73. PubMed ID: 24415881
[TBL] [Abstract][Full Text] [Related]
14. Validating the prognostic and discriminating value of the TNM-classification for gastric cancer - a critical appraisal.
Röcken C; Behrens HM
Eur J Cancer; 2015 Mar; 51(5):577-86. PubMed ID: 25682192
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy benefited the survival of patients with intestinal-type gastric adenocarcinoma: a SEER population-based study.
Chu Y; Xu B; Song Q; Hu Q
Clin Transl Oncol; 2021 Jan; 23(1):164-171. PubMed ID: 32488805
[TBL] [Abstract][Full Text] [Related]
16. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
17. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer.
Coburn NG; Swallow CJ; Kiss A; Law C
Cancer; 2006 Nov; 107(9):2143-51. PubMed ID: 17001662
[TBL] [Abstract][Full Text] [Related]
18. The recommended treatment strategy for locally advanced gastric cancer in elderly patients aged 75 years and older: a Surveillance, Epidemiology, and End Results database analysis.
Liu KT; Wan JF; Yu GH; Bei YP; Chen X; Lu MZ
J Cancer Res Clin Oncol; 2017 Feb; 143(2):313-320. PubMed ID: 27757528
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for surgery with adequate nodal evaluation alone in gastric adenocarcinoma?
Dudeja V; Habermann EB; Abraham A; Zhong W; Parsons HM; Tseng JF; Al-Refaie WB
J Gastrointest Surg; 2012 Feb; 16(2):238-46; discussion 246-7. PubMed ID: 22089951
[TBL] [Abstract][Full Text] [Related]
20. Modest overall survival improvements from 1998 to 2009 in metastatic gastric cancer patients: a population-based SEER analysis.
Ebinger SM; Warschkow R; Tarantino I; Schmied BM; Güller U; Schiesser M
Gastric Cancer; 2016 Jul; 19(3):723-34. PubMed ID: 26391158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
